Transforming Healthcare is a community lecture series that showcases the extraordinary medical advancements being pioneered at the University of Colorado Anschutz Medical Campus. Presented by Chancellor Donald M. Elliman, each lecture examines a different timely topic in research, science and healthcare.
The spring 2023 lecture celebrates the recently launched Gates Institute with a focus on its cutting-edge cancer research. Join us to learn how researchers at CU Anschutz are translating new cellular therapy discoveries into personalized cures to help patients worldwide.
This invitation-only event offers a unique opportunity to hear directly from the leading scientists whose research is revolutionizing the way we treat cancer and other diseases. Plus, meet some of the patients who have been treated with novel cellular therapeutics at CU Anschutz.
Tuesday, May 2, 2023, 5:30-7:30 p.m.
5:30 - 6:00 p.m. Reception | 6:00 - 7:30 p.m. Program
CU Anschutz Medical Campus, Anschutz Health Sciences Building
Elliman Conference Center (2nd floor), 1890 N. Revere Ct., Aurora
RSVP by April 26, 2023
Dr. Fry is a pediatric oncologist, renowned expert in CAR (chimeric antigen receptor) T-cell therapy, and director of cancer immunotherapy at the CU School of Medicine. As head of the recently established Gates Institute at CU Anschutz, Dr. Fry is working to advance novel CAR T-cell therapies from the lab to the clinic – his area of focus since leading first-in-human clinical trials for pediatric leukemia patients at the National Institutes of Health. In addition, he holds the Charles C. Gates Endowed Chair at the Gates Institute and serves as head of T cell therapeutics at Sana Biotechnology.
Dr. Verneris is a pediatric hematologist and oncologist at the CU School of Medicine and director of Bone Marrow Transplantation and Cellular Therapy at Children’s Hospital Colorado, where he holds the Barton Family Endowed Chair of Bone Marrow Transplant. Dr. Verneris specializes in pediatric leukemia, and his clinical research focuses on using the immune system to treat refractory cancer, whether through bone marrow transplantation or cellular therapy. His pioneering research has progressed the field of cellular therapy to greater heights, while advancing new cures and therapies that are saving lives.
Dr. Keating is an associate professor of pediatrics at the CU School of Medicine and medical director of the Blood Marrow Transplant and Cellular Therapeutics clinical program at Children’s Hospital Colorado. Dr. Keating specializes in pediatric blood and marrow transplants, and her discoveries are helping to drive the next generation of trailblazing new cancer cures. Her research focuses primarily on the development of clinical trials for pediatric leukemia patients, with a particular interest in cellular therapeutics to improve outcomes and reduce side effects for children with relapsed cancer.
Dr. Kamdar is an associate professor and the clinical director of the lymphoma program in the Division of Hematology at the CU School of Medicine. Her clinical research focuses primarily on chemotherapy-free cellular therapy, and her work is helping to advance more effective, less toxic treatments for the hardest-to-treat cancers. One of her recent studies showed tremendous promise in utilizing CAR T-cell therapies to improve survival rates for patients with relapsed large B-cell lymphoma, resulting in the first new treatment for the disease in 20+ years.
New Frontiers in Mental Health Treatment
November 1st, 2022
Amid a nationwide mental health crisis, Colorado ranks among the worst states for access to treatment and services. View this video to learn how CU Anschutz is shifting this paradigm by putting groundbreaking new psychiatric treatments and tools directly in the hands of providers and patients to improve mental health for all.
The Promise (and Proof) of RNA Research
April 26th, 2022
The Spring 2022 lecture featured the cutting-edge research of the CU School of Medicine’s RNA Bioscience Initiative (RBI). Our renowned team of RBI researchers shared how their RNA breakthroughs are transforming the future of medicine, opening up a wide range of new treatments, tools and therapies.
Breakthroughs in Cancer Treatment and Care
February 4th, 2020
This Transforming Healthcare lecture series, presented by CU Anschutz Chancellor Don Elliman, will feature the top University of Colorado Cancer Center doctors who are working on cutting-edge techniques to diagnose, treat, and prevent cancer in adults and children.
Breakthroughs in Orthopedics
November 4th, 2019
The University of Colorado School of Medicine’s Department of Orthopedics offers Colorado and the Rocky Mountain region and range and depth of expertise in spine, joint, and limb repair and care.